Delivery Order SPE2DB20D3101-SPE2DB25FRLJ9
Award Date 5/28/25
Potential Completion Date 5/29/25
Potential Value $2.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $27,766.85 to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count supply) on August 12, 2025, with an ultimate completion date of August 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $2,487.53 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count supply) on August 21, 2025, with completion targeted for August 22, 2025. This firm fixed-price, non-set-aside delivery order is being performed in Conshohocken, Pennsylvania, the vendor's corporate headquarters location. The award represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply portfolio to federal customers. This...
- The Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $2,154.60 on June 17, 2025, for the supply of Ondansetron ODT 8 mg tablets in a 30-count package. The contract employs firm fixed price pricing with an ultimate completion date of June 18, 2025, and represents a non-competitive award. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $9,213.92 to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count) on September 9, 2025, with completion targeted for September 10, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's Conshohocken, Pennsylvania location. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order valued at $28,026.72 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count packages). This competitively awarded, firm fixed price delivery order was issued on August 12, 2025, with an ultimate completion date of August 13, 2025, and carries no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its...
- The Defense Logistics Agency awarded a $2,877.66 firm fixed price delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count units) with an ultimate completion date of June 2, 2025. This non-set-aside contract represents a standard pharmaceutical supply transaction under the company's broader relationship with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a $7,527.37 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count units) with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical federal healthcare vendor that...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count packages) under a firm fixed-price arrangement. The contract, valued at $6,498.61, was competitively awarded without set-aside designation and is scheduled for completion by June 23, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $19,039.16 by the Defense Logistics Agency's Medical Supply Chain on August 19, 2025, for the supply of Ondansetron Orally Disintegrating Tablet 8 mg in quantities of 30 tablets. This firm fixed-price delivery order, which is not set-aside, represents a non-competitive award under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $35,913.34 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count) on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance, which aligns with the contractor's corporate headquarters location. The award represents a...